CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3 enrolled
Drug / intervention
DBSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05522751
NCT05522751N/ACompleted
CompareCT.gov

Limbic Pallidum Deep Brain Stimulation for the Treatment of Severe Alcohol Use Disorder

Khaled Moussawi·interventional·Posted Aug 31, 2022·Updated Aug 15, 2025

In Brief

A clinical study evaluating DBS for Alcohol Use Disorder. Completed, enrolled 3 participants across 1 site.

Detailed Summary

The purpose of this clinical study is to investigate the safety, tolerability, and feasibility of Deep Brain Stimulation (DBS) of the limbic pallidum in participants with severe alcohol use disorder (AUD) who have advanced but compensated liver fibrosis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Use Disorder
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

Timeline

N/ACompletedFinished
2023202420252026
First PostedAug 31, 2022
Enrollment StartJan 10, 2023
Primary CompletionMay 20, 2024
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 3.8 years ago

Interventions

DBSdevice

Bilateral DBS electrodes will be implanted into the limbic pallidum of participants with severe alcohol use disorder and advanced but compensated liver disease.